Dataset Information

Pathologic features and molecular identification of parelaphostrongylosis in a sitatunga (Tragelaphus spekii).

ABSTRACT: We report the pathologic features, local inflammatory response immunophenotype, and molecular identification results of cerebral nematodiasis in a young sitatunga (Tragelaphus spekii) from Texas. To the authors' knowledge, this is the first report of cerebral nematodiasis by Parelaphostrongylus tenuis in a sitatunga, a bovid species introduced into the USA, and the first characterization of the local inflammatory response immunoprofile in this condition. A molecular identification method based on formalin-fixed and paraffin-embedded-polymerase chain reaction was described. These results contribute to knowledge on geographical distribution and host spectrum of P. tenuis, and highlight the relevance of this nematodiasis in naïve translocated or introduced bovid species into endemic areas.

SUBMITTER: Diaz-Delgado J

PROVIDER: S-EPMC8498824 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Pathologic features and molecular identification of parelaphostrongylosis in a sitatunga (Tragelaphus spekii).

Díaz-Delgado Josué J Cruz David D Sobotyk Caroline C Hensley Terry T Anguiano Maritza M Verocai Guilherme G GG Gomez Gabriel G

The Journal of veterinary medical science 20210731 9

We report the pathologic features, local inflammatory response immunophenotype, and molecular identification results of cerebral nematodiasis in a young sitatunga (Tragelaphus spekii) from Texas. To the authors' knowledge, this is the first report of cerebral nematodiasis by Parelaphostrongylus tenuis in a sitatunga, a bovid species introduced into the USA, and the first characterization of the local inflammatory response immunoprofile in this condition. A molecular identification method based o ...[more]

PMID: 34334513

Similar Datasets

Project description:Pineoblastomas (PBs) are rare, aggressive pediatric brain tumors of the pineal gland with modest overall survival despite intensive therapy. We sought to define the clinical and molecular spectra of PB to inform new treatment approaches for this orphan cancer. Tumor, blood, and clinical data from 91 patients with PB or supratentorial primitive neuroectodermal tumor (sPNETs/CNS-PNETs), and 2 pineal parenchymal tumors of intermediate differentiation (PPTIDs) were collected from 29 centres in the Rare Brain Tumor Consortium. We used global DNA methylation profiling to define a core group of PB from 72/93 cases, which were delineated into five molecular sub-groups. Copy number, whole exome and targeted sequencing, and miRNA expression analyses were used to evaluate the clinico-pathologic significance of each sub-group. Tumors designated as group 1 and 2 almost exclusively exhibited deleterious homozygous loss-of-function alterations in miRNA biogenesis genes (DICER1, DROSHA, and DGCR8) in 62 and 100% of group 1 and 2 tumors, respectively. Recurrent alterations of the oncogenic MYC-miR-17/92-RB1 pathway were observed in the RB and MYC sub-group, respectively, characterized by RB1 loss with gain of miR-17/92, and recurrent gain or amplification of MYC. PB sub-groups exhibited distinct clinical features: group 1-3 arose in older children (median ages 5.2-14.0 years) and had intermediate to excellent survival (5-year OS of 68.0-100%), while Group RB and MYC PB patients were much younger (median age 1.3-1.4 years) with dismal survival (5-year OS 37.5% and 28.6%, respectively). We identified age < 3 years at diagnosis, metastatic disease, omission of upfront radiation, and chr 16q loss as significant negative prognostic factors across all PBs. Our findings demonstrate that PB exhibits substantial molecular heterogeneity with sub-group-associated clinical phenotypes and survival. In addition to revealing novel biology and therapeutics, molecular sub-grouping of PB can be exploited to reduce treatment intensity for patients with favorable biology tumors.

Dataset Information

Pathologic features and molecular identification of parelaphostrongylosis in a sitatunga (Tragelaphus spekii).

Publications

Pathologic features and molecular identification of parelaphostrongylosis in a sitatunga (Tragelaphus spekii).

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets